Envestnet Asset Management
MITO

Envestnet Asset Management’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Envestnet Asset Management’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,248
Closed -$7K – 4124
2022
Q3 		$7K Buy
23,248
+5,404
+30% +$1.54K ﹤0.01% 3888
2022
Q2 		$5K Buy
17,844
+3,619
+25% +$1.25K ﹤0.01% 3909
2022
Q1 		$10K Buy
14,225
+1,808
+15% +$1.22K ﹤0.01% 3923
2021
Q4 		$10K Buy
+12,417
New +$12.9K ﹤0.01% 3860

Envestnet Asset Management's MITO Position: Q4 2022 in Review

Envestnet Asset Management sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 23,248 shares — an estimated $7K sold.

Envestnet Asset Management first reported a position in MITO in Q4 2021 and held it in 4 quarters. The position peaked at $10K in Q1 2022. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

  • Envestnet Asset Management reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 23,248 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $7K.
  • Envestnet Asset Management first reported a position in Stealth BioTherapeutics Corp. ADS in Q4 2021 and held it in 4 quarters.
  • Envestnet Asset Management's Stealth BioTherapeutics Corp. ADS position peaked at $10K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Envestnet Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.